Vice President, Obesity Strategy

Senior enterprise executive to define and own Pfizer’s global obesity strategy across the U.S. and China, owning end-to-end strategic and financial ownership for the obesity franchise, setting long-term direction, guiding portfolio strategy and capital allocation, and leading cross-functional execution across R&D, Commercial, Medical, and Development with external representation and thought leadership; requires deep obesity/metabolic expertise and 12–15+ years in pharma/biotech with senior leadership accountability; hybrid role requiring 2.5 days on-site weekly within commuting distance; base salary $300,100–$500,100 with bonus eligibility, relocation possible; U.S. work authorization required and U.S. visa sponsorship not available.